Fan, W., Zhang, W., Wu, Y., Zhao, Y., Wen, J., Xue, M., Ge, N., Li, H., Yang, G. C., Shang, C. (2026). Donafenib plus transarterial chemoembolization (TACE) with or without anti–PD-1 antibodies for unresectable hepatocellular carcinoma second-line or later therapies: A retrospective multicenter study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16208